Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zenflow Spring System vs Tamsulosin for LUTS/BPH
NCT07797348Phase 4Not yet recruiting
- Sponsor
- Zenflow
- Start
- Sep 2026
- Primary completion
- Sep 2028
01
Overview
Phase 4, randomised, open-label trial in benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS) (2 arms), sponsored by Zenflow. Primary endpoints: International Prostate Symptom Score at 3 months and Serious Adverse Events at 1 year. Planned start Sep 2026; status: not yet recruiting.
02
Conditions
benign prostatic hyperplasia (BPH)lower urinary tract symptoms (LUTS)
Beyond the preview
Go deeper on NCT07797348.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07797348.